logo
Officials to test water from Ohio village near Cold War-era weapons plant after newspaper probe

Officials to test water from Ohio village near Cold War-era weapons plant after newspaper probe

LUCKEY, Ohio (AP) — Authorities in Ohio plan to test the groundwater supply across a village near a former weapons plant after a newspaper investigation published Friday found high levels of radioactivity in samples taken at a school, athletic field, library and other sites.
The Army Corps of Engineers has been removing tons of contaminated soil from the Cold War-era site since 2018 and has long maintained that residential areas were not affected by the work.
However, The Toledo Blade said its tests showed radioactivity levels 10 times higher than normal in water from a drinking fountain at Eastwood Middle School, 45 times higher than normal at the Luckey Library and 1,731 times higher than normal at a water pump near athletic fields.
'We've got to get to the bottom of this,' said Lt. Col. Robert Burnham, commander of the U.S. Army Corps of Engineers' Buffalo District, which oversees the cleanup.
Nineteen of the 39 samples collected by the newspaper from well water across Luckey — at homes, businesses, and public places — showed radioactivity at least 10 times greater than what the federal government calls normal for the area, the newspaper said. The Blade hired an accredited private lab to conduct the testing.
The radioactivity detected was primarily bismuth-214, which decays from the radioactive gas radon-222. Experts agree that high levels of bismuth-214 suggest high levels of radon are also present.
Radon exposure is the leading cause of lung cancer in nonsmokers.
The testing also found low levels of radioactive cobalt-60, a man-made isotope, in two wells. Experts called that finding extremely rare.
Taehyun Roh, a Texas A&M University scientist who specializes in environmental exposures, said regulators should also conduct air and soil testing to assess the extent of the contamination and identify the source.
'Since this area likely has high radon levels, testing for radon in both air and water is advisable,' he wrote in an email. 'A safe drinking water advisory should be issued, recommending the use of bottled water until further assessments and mitigation measures are in place.'
The Corps of Engineers has long maintained that residential drinking water was not being contaminated by the removal work. Burnham and others said they still believe that to be true, citing thousands of their own soil samples.
The state Environmental Protection Agency and Department of Health will lead the testing. In an email, Ohio EPA spokesperson Katie Boyer told the newspaper the contaminant levels in the public drinking water are still 'within acceptable drinking water standards.' She said any concerns raised by the state testing would be addressed.
The 44-acre industrial site — 22 miles (35 kilometers) south of Toledo — was long crucial to America's nuclear weapons program. In the 1940s, farmland was replaced by a sprawling defense plant that produced magnesium metal for the Manhattan Project. In the 1950s, the plant became the government's sole source of beryllium metal for nuclear bombs, Cold War missiles and Space Race products, including a heat shield for Project Mercury.
'Things that happened generations ago are still affecting us,' said Karina Hahn-Claydon, a 50-year-old teacher whose family lives less than a mile from the site. 'And that's because the government didn't take care of it.'
Private drinking wells, unlike municipal systems, are not regulated, and responsibility for testing is left to owners. The Blade's testing took place from April 2024 through January.
Radioactivity has been linked to an increased risk of various cancers, including blood and thyroid cancers.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gaza war death toll surpasses 62,000, says Palestinian Health Ministry
Gaza war death toll surpasses 62,000, says Palestinian Health Ministry

The Hill

time9 hours ago

  • The Hill

Gaza war death toll surpasses 62,000, says Palestinian Health Ministry

CAIRO (AP) — The Palestinian Health Ministry said on Monday that more than 62,000 Palestinians have been killed in the 22-month war in Gaza. At least 60 people were killed in the past 24 hours, bringing the death toll from the Israel-Hamas war that started on Oct. 7, 2023, to 62,004. Another 156,230 have been wounded, it said. The Health Ministry said 1,965 people have been killed while seeking aid from aid convoys or killed close to aid distribution sites. At least seven Palestinians were killed attempting to access aid on Monday morning. The ministry, which doesn't distinguish between civilians and combatants in its count, is staffed by medical professionals. The United Nations and other independent experts view its figures as the most reliable count of casualties. Israel has disputed its figures, but hasn't provided its own account of casualties. The Palestinian Health Ministry said on Monday that more than 62,000 Palestinians have been killed in the 22-month Gaza war. At least 60 people were killed in the past 24 hours, bringing the death toll from the Israel-Hamas war that started on Oct. 7, 2023 to 62,004. Another 156,230 have been wounded, it said. The Health Ministry said 1,965 people were killed while seeking aid from aid convoys or killed close to aid distribution sites. At least seven Palestinians were killed attempting to access aid on Monday morning. Also on Monday, Egypt's top diplomat condemned Israel's plan to forcibly resettle Palestinians outside of Gaza and said the country is attempting to restart ceasefire negotiations along with Qatar. Mediators are 'exerting extensive efforts' to revive a U.S. proposal for a 60-day ceasefire during which the warring parties will negotiate an end to the war, Egyptian Foreign Minister Badr Abdelatty said on the Egyptian side of a crossing between Egypt and Gaza. He met there with Palestinian Prime Minister Mohammad Mustafa.

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock
Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

Yahoo

time16 hours ago

  • Yahoo

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her 'Buy' rating, expecting long-term value despite reducing the price objective to $300. The analyst noted that the company has reinstated its 2025 earnings guidance. The analyst believes that pricing pressure and increased medical cost trends will continue into 2026. Furthermore, the analyst also highlighted the underperformance in Optum Health's value-based care and Optum Insight segments. Despite these factors, Hynes opines that UnitedHealth Group Incorporated (NYSE:UNH)'s scale, market position, and diversified business are the key strengths, and believes that the stock's valuation is attractive. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH)'s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided by growth in UnitedHealthcare and Optum. Notably, the Q2 2025 consolidated medical care ratio stood at 89.4%, reflecting an increase of 430 bps YoY. This was mainly because of medical cost trends, which significantly surpassed pricing trends, such as both unit costs and the intensity of services delivered, and the ongoing impacts of Medicare funding reductions. Hotchkis & Wiley, an investment management company, released its Q2 2025 investor letter and mentioned UnitedHealth Group Incorporated (NYSE:UNH). Here is what the fund said: 'UnitedHealth Group Incorporated (NYSE:UNH) is a large US health insurer. Until very recently, UNH traded at a material premium to its peers, reflecting its status as a premium growth stock with momentum. We did not own the stock. However, recent negative headlines, combined with the first earnings miss in 10 years, resulted in a >50% selloff in the company's shares. This decline contributed positively to the strategy's relative performance vs. the index, where UNH was a meaningful weight. We purchased UNH shares after the selloff at what we believe is a compelling valuation.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock
Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

Yahoo

time16 hours ago

  • Yahoo

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her 'Buy' rating, expecting long-term value despite reducing the price objective to $300. The analyst noted that the company has reinstated its 2025 earnings guidance. The analyst believes that pricing pressure and increased medical cost trends will continue into 2026. Furthermore, the analyst also highlighted the underperformance in Optum Health's value-based care and Optum Insight segments. Despite these factors, Hynes opines that UnitedHealth Group Incorporated (NYSE:UNH)'s scale, market position, and diversified business are the key strengths, and believes that the stock's valuation is attractive. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH)'s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided by growth in UnitedHealthcare and Optum. Notably, the Q2 2025 consolidated medical care ratio stood at 89.4%, reflecting an increase of 430 bps YoY. This was mainly because of medical cost trends, which significantly surpassed pricing trends, such as both unit costs and the intensity of services delivered, and the ongoing impacts of Medicare funding reductions. Hotchkis & Wiley, an investment management company, released its Q2 2025 investor letter and mentioned UnitedHealth Group Incorporated (NYSE:UNH). Here is what the fund said: 'UnitedHealth Group Incorporated (NYSE:UNH) is a large US health insurer. Until very recently, UNH traded at a material premium to its peers, reflecting its status as a premium growth stock with momentum. We did not own the stock. However, recent negative headlines, combined with the first earnings miss in 10 years, resulted in a >50% selloff in the company's shares. This decline contributed positively to the strategy's relative performance vs. the index, where UNH was a meaningful weight. We purchased UNH shares after the selloff at what we believe is a compelling valuation.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store